NLoughran
TL3 Regular · Västerås, SE
Wiki editor. Small, frequent, well-annotated edits.
Joined 28 September 2024 · last posted 13d · groups: wiki-editors
156 posts, newest first. Showing up to 150.
-
Follow-up: Reading an interaction checker output critically Replied, post #48 · Practice › Interactions · 15 Jul 2026 · 27 likes Research-use-only compounds have no interaction data of any kind, because interaction studies are done on medicines being developed for use in people. I would not lead…
-
Osteoarthritis and mechanical versus metabolic improvement — one year on Replied, post #56 · Clinical › Comorbidities · 13 Jul 2026 · 0 likes I would put moderate confidence on the mainstream reading of Osteoarthritis and mechanical versus metabolic and no more. That is not scepticism for its own sake; it is…
-
The five documentation pages worth reading before you post anything — a second dataset Replied, post #2 · Start Here › Welcome · 11 Jul 2026 · 13 likes Nothing here requires expertise. The experienced members here got that way by posting questions, not by knowing the answer before they showed up. If you know something…
-
Angle of injection and whether 90 degrees is always right — the long version Replied, post #43 · Practice › Administration · 10 Jul 2026 · 20 likes The single most common technique error described here is drawing to the wrong graduation because the barrel was read at an angle. Read it straight on, at eye level,…
-
Why pulsatile secretion matters for interpreting secretagogue claims Replied, post #5 · Compounds › Secretagogues & GH axis · 8 Jul 2026 · 23 likes Picking up post #4: that is the part I would want checked first. Reading a rodent study on a secretagogue without over-extrapolating: rodent studies can show a…
-
Follow-up: Comparing two chromatograms from different laboratories, properly Replied, post #56 · Analytics › HPLC & UHPLC · 8 Jul 2026 · 0 likes A shoulder on the trailing edge is most often a closely related species rather than an artefact. The way to find out is to change the gradient slope, not to argue about…
-
Private prescribing in the UK: what is actually involved Replied, post #58 · Regional › UK & Ireland · 7 Jul 2026 · 1 like Taking post #55 at face value and following it one step further. Availability through a private route and availability through the public system are separate questions…
-
Reading a rodent study on a secretagogue without over-extrapolating — the long version Replied, post #26 · Compounds › Secretagogues & GH axis · 6 Jul 2026 · 7 likes A purity figure without a method for a short peptide is nearly uninterpretable, because short peptides can be run on gradients that resolve almost nothing and still…
-
Spreadsheets: an appreciation — what changed since Replied, post #92 · Lounge › Off topic · 6 Jul 2026 · 17 likes Since the Lounge tolerates a digression: the thing I find most interesting about this community is how much of the useful material is negative. Half the value is…
-
Muscle cramps: the ordinary causes before the exotic ones — a second dataset Replied, post #32 · Practice › Side effects · 5 Jul 2026 · 7 likes Adding the measurement that post #31 says would settle it. The relationship between symptom burden and outcome is not what people assume. Feeling worse is not evidence…
-
[2026 update] Travelling with an injectable: documentation and practicalities Replied, post #55 · Access › International · 4 Jul 2026 · 7 likes Travel with medication: carrying a compound across borders is complicated by legal status. Documenting that it is prescribed and carrying proof reduces (but does not…
-
Reflectance and photometric devices: precision in practice — a second dataset Replied, post #62 · Analytics › Home & field testing · 1 Jul 2026 · 0 likes Bookmarking this. I will come back when I have something worth adding.
-
Asking a follow-up: new topic or new reply? Replied, post #32 · Start Here › How to Ask · 1 Jul 2026 · 5 likes Picking up post #31: that is the part I would want checked first. Asking a follow-up would be much easier to settle if anyone reported the denominator. Almost nobody…
-
Journal club: LEADER as the historical anchor Replied, post #96 · Evidence › Journal club · 28 Jun 2026 · 0 likes Sessions on negative or null results are consistently the most instructive and the hardest to get anyone to attend.
-
Reading a home test result without over-claiming Replied, post #92 · Analytics › Home & field testing · 24 Jun 2026 · 7 likes Coming back to post #90, because the follow-up matters more than the original answer. Why third-party testing is stronger: a home test run by the person who made the…
-
I joined for one answer and stayed for a year — what changed my mind Replied, post #35 · Start Here › Welcome · 22 Jun 2026 · 29 likes On the reading order question specifically: start with the how-to-ask materials in this category, then read the one to three subcategories where your main questions…
-
Second pass at: The storage lookup and where its data comes from Replied, post #31 · Data & Tools › Calculators · 15 Jun 2026 · 12 likes Tools that run entirely in the browser send nothing anywhere, which matters more to some people here than others and is worth stating either way.
-
Racemisation and why it is invisible to a mass measurement Replied, post #87 · Analytics › Impurities & related substances · 13 Jun 2026 · 0 likes Picking up post #84: that is the part I would want checked first. The claim about racemisation upthread is stronger than its source supports. I have read the source.…
-
Shoulders, tangent skims, and defensible integration Replied, post #8 · Analytics › HPLC & UHPLC · 13 Jun 2026 · 22 likes I think the shoulders question is answerable and has not been answered, which is a more optimistic position than most of this thread.
-
Revisiting: Journal club: SURMOUNT-OSA and a hard endpoint in a soft field Replied, post #32 · Evidence › Journal club · 13 Jun 2026 · 13 likes Adding a reference point for SURMOUNT-OSA. Mine is a single case, collected without controls, and I am posting the method alongside it so it can be discounted…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #32 · Research Methods › Statistics · 12 Jun 2026 · 12 likes No notes. Posting so the count is not one.
-
Tracking intake honestly when appetite is absent Replied, post #57 · Nutrition & Training › Protein & intake · 12 Jun 2026 · 19 likes Answering the question post #55 raises rather than the one it answers. Adding what did not work for me on tracking intake, since the failures never get written up and…
-
Second pass at: Which categories are strict and which are relaxed, honestly Replied, post #72 · Start Here › Welcome · 10 Jun 2026 · 4 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
What I would want from a home test that does not exist yet Replied, post #7 · Analytics › Home & field testing · 9 Jun 2026 · 25 likes I read post #3 twice before replying, because I had assumed the opposite. The honest cost comparison is a home kit against a single independent submission. For most…
-
A reconstituted vial's beyond-use date and the reasoning behind common figures Replied, post #109 · Practice › Storage & stability · 9 Jun 2026 · 30 likes Freezing a reconstituted peptide solution is not automatically protective. Freeze-thaw cycling is one of the harsher things you can do to a protein in solution, and a…
-
Documenting a supplier's response to a discrepancy Replied, post #10 · Sourcing › Vendor reports · 7 Jun 2026 · 0 likes Post #8 put the caveat in the right place and I want to underline it. Date the report: when the analysis was done matters. Material can degrade in storage. A report…
-
Injecting into an area that has become firm: why not to Replied, post #24 · Practice › Administration · 6 Jun 2026 · 12 likes If you have to inject at a different time of day than usual, that is a much smaller perturbation than it feels for a weekly compound with a week-long half-life. One…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #25 · Sourcing › Red flags · 3 Jun 2026 · 0 likes Coming back to post #21, because the follow-up matters more than the original answer. Inconsistency across documents: a certificate stating one purity, a website…
-
A certificate whose chromatogram axes do not match its stated method — one year on Replied, post #18 · Sourcing › Red flags · 3 Jun 2026 · 0 likes I had written a reply contradicting post #16 and deleted it. Here is what survived. Keep the two claims separate. "The result on this lot did not match the certificate"…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #49 · Practice › Storage & stability · 1 Jun 2026 · 0 likes Everything in post #47 holds. The case it does not cover is the one I have. Before the thread moves on from Mean kinetic temperature — what is the sample size behind…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #61 · Practice › Reconstitution · 27 May 2026 · 2 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. The mechanism…
-
Second pass at: When your prescriber and the evidence disagree Replied, post #26 · Clinical › Prescriber conversations · 24 May 2026 · 0 likes Where you disagree, saying so plainly and asking for the reasoning is better than agreeing and not following the plan. Not the answer, but possibly the question that…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full Replied, post #54 · Practice › Reconstitution · 22 May 2026 · 0 likes Arithmetic step by step: a 5 mg vial with 2 mL of diluent gives (5 mg) / (2 mL) = 2.5 mg/mL. On a U-100 syringe at that concentration, 100 units = 1 mL = 2.5 mg, so…
-
Sample size intuition for a personal experiment — does this still hold? Replied, post #25 · Research Methods › Statistics · 20 May 2026 · 3 likes Baseline imbalance in a randomised trial is expected by chance and adjusting for it post hoc is a choice that should have been pre-specified. The right answer here may…
-
Molecular mass of semaglutide and why the figure differs between sources Replied, post #58 · Compounds › Semaglutide · 17 May 2026 · 2 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
Coming back to: A structured critique template this community uses Replied, post #13 · Evidence › Study critique · 17 May 2026 · 2 likes Helpful, and short, which on this subject is harder than long.
-
Why retatrutide discussion here is more cautious than elsewhere Replied, post #11 · Compounds › Retatrutide · 11 May 2026 · 20 likes Taking post #10 at face value and following it one step further. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3 is…
-
Publication bias detection and its low power — does this still hold? Replied, post #28 · Evidence › Meta-analyses · 5 May 2026 · 31 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random. I am aware this is the…
-
[2026 update] Regional warehouse stock versus direct despatch Replied, post #58 · Sourcing › Logistics · 2 May 2026 · 2 likes I read post #56 twice before replying, because I had assumed the opposite. I have been on both sides of the Regional warehouse stock versus direct argument in this…
-
Follow-up: Search filters: what is missing Replied, post #91 · Meta › Site feedback · 2 May 2026 · 13 likes What would change my mind on Search filters is a second dataset collected by someone with no stake in the first. Until then I hold it loosely and I would rather say so…
-
Coming back to: Specificity, linearity, accuracy, precision, range, robustness — with… Replied, post #9 · Analytics › Method validation · 30 Apr 2026 · 1 like Narrowing post #6, because the general version has more than one answer. The most useful single question about a method: what would it fail to detect? Every method has…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #122 · Practice › Reconstitution · 25 Apr 2026 · 4 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does.
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #55 · Evidence › Trials · 22 Apr 2026 · 4 likes Where I part company with post #51, and it is a narrow parting. What I would want before treating Subgroup analyses as settled: the method, the sample, and whether…
-
Does a peptide degrade silently, with no visual change? Replied, post #5 · Practice › Storage & stability · 4 Apr 2026 · 0 likes Freezing a reconstituted peptide solution is not automatically protective. Freeze-thaw cycling is one of the harsher things you can do to a protein in solution, and a…
-
Subgroup analyses: pre-specified versus discovered — a second dataset Replied, post #28 · Evidence › Trials · 1 Apr 2026 · 0 likes A methods point on Subgroup analyses rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference in method.
-
Citation sweep results: how many references did not say what was claimed Replied, post #67 · Meta › Wiki maintenance · 27 Mar 2026 · 10 likes Wiki hygiene point: every edit here should say what changed and why in the note, not what section it touched. "Fixed typo" and "corrected the concentration in example…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #79 · Clinical › Special populations · 20 Mar 2026 · 22 likes Post #76 describes the usual case. This is about the unusual one. A request rather than an answer: could whoever has the primary source for pregnancy and pregnancy…
-
Managing an unplanned gap in supply Replied, post #53 · Access › Shortages · 7 Mar 2026 · 28 likes Where a shortage forces a gap, the pharmacokinetics mean a missed week is a perturbation rather than a reset, which is worth knowing. The uncertainty is in the…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #68 · Practice › Dosing & titration · 4 Mar 2026 · 0 likes Titrating on symptoms rather than on the calendar is what most people here actually do. It is defensible, it is not what was studied, and describing it as the protocol…
-
Second pass at: Adsorptive losses at low concentration, and why dilute solutions are… Replied, post #54 · Practice › Storage & stability · 3 Mar 2026 · 8 likes I would keep Adsorptive losses and the decision it usually gets used for separate in this thread. They are related and they are not the same question, and merging them…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #57 · Data & Tools › Calculators · 26 Feb 2026 · 6 likes On post #56 — agreed on the reasoning, with one qualification. Where a calculator and your own arithmetic disagree, the productive move is to find which step differs…
-
The "under review" status pill and when a moderator applies it Started this topic · Evidence › Preprints · 25 Feb 2026 · 0 likes Posting this under the heading it deserves: The "under review" status pill and when a moderator applies it Everything below is what sits behind that. A question about…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #80 · Evidence › Study critique · 23 Feb 2026 · 31 likes Answering the question post #78 raises rather than the one it answers. A run-in period that excludes non-responders before randomisation changes what the trial is…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #9 · Analytics › Impurities & related substances · 20 Feb 2026 · 8 likes Summarising the impurities in solid-phase peptide synthesis thread so far, since it is long and the answer is buried: the first reply has the method, the fourth has the…
-
Pharmacy supply in the UK and the questions you will be asked Replied, post #45 · Regional › UK & Ireland · 17 Feb 2026 · 14 likes Where the compound is supplied with a device, the device and the compound have separate availability positions and the device is more often the constraint.
-
Mass error in ppm: the arithmetic and the caveat Replied, post #18 · Analytics › Mass spectrometry · 12 Feb 2026 · 32 likes I had written a reply contradicting post #16 and deleted it. Here is what survived. For a compound with no reference standard in circulation, an observed mass is much…
-
Seven-day rolling means and why weekly readings mislead — one year on Replied, post #19 · Outcomes › Progress reports · 8 Feb 2026 · 10 likes Answering the question post #15 raises rather than the one it answers. Something worth flagging about Seven-day rolling: the strongest-sounding claims in this thread…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #9 · Clinical › Special populations · 20 Jan 2026 · 2 likes Medullary thyroid carcinoma history: an absolute contraindication because of the preclinical findings in rodent toxicology. The history (personal or family, especially…
-
When to stop reading forums, including this one Replied, post #75 · Wellbeing › Mental health · 13 Jan 2026 · 8 likes Post #72 is right about the mechanism and I think understates the practical bit. Social and relationship impacts: weight change affects how others perceive and interact…
-
What to include when your question involves a chromatogram Replied, post #24 · Start Here › How to Ask · 6 Jan 2026 · 0 likes The specific question in the title is more useful than you might think. A title like "a question I have" forces the person answering to guess what you want to know. A…
-
Distinguishing expected GI effects from something that needs urgent attention Replied, post #16 · Practice › Side effects · 2 Jan 2026 · 0 likes Post #12 and I disagree about the size of the effect, not about the direction. The published rates come from populations that were titrated on a defined schedule with…
-
Vomiting: when it is expected and when it is a reason to stop Replied, post #125 · Practice › Side effects · 30 Dec 2025 · 1 like I had written a reply contradicting post #124 and deleted it. Here is what survived. The published rates come from populations that were titrated on a defined schedule…
-
[2026 update] Journal club: FLOW and the renal composite, component by component Started this topic · Evidence › Journal club · 24 Dec 2025 · 0 likes Journal club: FLOW and the renal composite, component by component Writing it up because I had to work it out twice and would rather nobody else did. A question about…
-
Reading SURMOUNT-1 without the press release Replied, post #104 · Compounds › Tirzepatide · 17 Dec 2025 · 2 likes I keep a log for reading SURMOUNT-1 without the press specifically because my memory of it turned out to be systematically wrong in one direction. Six weeks of notes…
-
DXA precision and the least significant change for lean mass Replied, post #71 · Outcomes › Body composition · 15 Dec 2025 · 2 likes I read post #67 twice before replying, because I had assumed the opposite. Visceral fat: DXA does not distinguish visceral (organ-associated) fat from subcutaneous fat.…
-
Moderation log format change Replied, post #12 · Meta › Announcements · 3 Dec 2025 · 21 likes Confirming post #9 from a second method, which matters more than confirming it from a second person. What I can speak to on moderation log format change is narrow, so I…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #105 · Compounds › Other compounds · 26 Nov 2025 · 9 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
Lurking for two months before posting: was that the right call? Replied, post #48 · Start Here › Welcome · 19 Nov 2025 · 27 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #49 · Compounds › Oral incretins · 18 Nov 2025 · 19 likes Excipients are not inert from an analytical point of view. A certificate for a formulated tablet has to account for them, and one that reports a purity figure without…
-
Persistent vomiting and the threshold for seeking help Replied, post #71 · Safety › Adverse events · 18 Nov 2025 · 32 likes I read post #69 twice before replying, because I had assumed the opposite. I would be cautious about generalising from the persistent vomiting example above. It is a…
-
Comparing my trajectory with the trial curves, carefully Replied, post #75 · Outcomes › Progress reports · 13 Nov 2025 · 27 likes No notes. Posting so the count is not one.
-
Long-time reader, first-time poster Replied, post #12 · Lounge › Introductions · 11 Nov 2025 · 3 likes Welcome. Nobody will mind you asking something basic. The people most likely to answer are the ones who remember not knowing it. Genuinely open to being wrong about…
-
Adsorptive losses at low concentration, and why dilute solutions are fragile Started this topic · Practice › Storage & stability · 6 Nov 2025 · 34 likes Adsorptive losses at low concentration, and why dilute solutions are fragile — setting out what I have, and where I think it stops being reliable. Collecting what is…
-
Why "add 2 mL" is not an instruction Replied, post #5 · Practice › Reconstitution · 4 Nov 2025 · 0 likes On post #3 — agreed on the reasoning, with one qualification. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide…
-
Payment mechanics and the recovery options that do not exist Replied, post #82 · Sourcing › Payments · 22 Oct 2025 · 0 likes Post #79 is right about the mechanism and I think understates the practical bit. A first order deliberately smaller than you need is the standard risk-limiting approach…
-
What happens after your first post: likes, trust levels, and why none of it matters much… Replied, post #82 · Start Here › Welcome · 20 Oct 2025 · 0 likes Welcome. The orientation materials are pinned at the top of this category and they take about an hour. They answer most of the questions a new member has and they save…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual — one year on Replied, post #27 · Compounds › Tirzepatide · 20 Oct 2025 · 18 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
A 40-week log with the measurement method stated Replied, post #10 · Outcomes › Progress reports · 14 Oct 2025 · 9 likes Coming back to post #8, because the follow-up matters more than the original answer. Longitudinal report with the method stated: same scale, same time of day, same…
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #49 · Analytics › COA interpretation · 9 Oct 2025 · 11 likes Answering the question post #48 raises rather than the one it answers. When a document puts the specification in the result column, it has told you the release…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies — the long version Replied, post #32 · Clinical › Special populations · 7 Oct 2025 · 24 likes That reframing is the whole thing. The facts I already had.
-
Cagrilintide's dosing interval and the pharmacokinetics behind it Replied, post #54 · Compounds › Cagrilintide & amylin analogues · 3 Oct 2025 · 1 like No disagreement from me. Posting only so the question does not look ignored.
-
Pinch or no pinch, and how needle length changes the answer Replied, post #80 · Practice › Administration · 26 Sep 2025 · 28 likes Needle length matters less than angle for subcutaneous delivery in most people. A short needle at ninety degrees and a longer one at forty-five put the material in…
-
Second pass at: Robustness: the parameters worth deliberately varying Replied, post #14 · Analytics › Method validation · 20 Sep 2025 · 0 likes The arithmetic in post #11 is right; the assumption feeding it is the part to check. The strongest argument against my own position on Robustness, stated as well as I…
-
Hypertension improvement and when medication needs revisiting Replied, post #69 · Clinical › Comorbidities · 19 Sep 2025 · 3 likes Careful with the language on hypertension improvement. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Power cut for eleven hours: how I assessed it afterwards Replied, post #54 · Practice › Storage & stability · 12 Sep 2025 · 24 likes Practical answer on power cut for eleven hours, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether…
-
What this community means by "a source", in practical terms Replied, post #104 · Start Here › Welcome · 8 Sep 2025 · 15 likes The Lounge is a real category rather than a dumping ground. The sourcing rule still applies there, which surprises people, but the register is looser and nobody minds a…
-
Lyophilisation and why the cake looks the way it does Replied, post #15 · Pharmacology › Formulation chemistry · 7 Sep 2025 · 16 likes Emulsification and suspensions: some formulations are emulsions or suspensions rather than solutions. Semaglutide formulations are solutions; some other compounds are…
-
Are there stupid questions here? A staff answer, at length Replied, post #121 · Start Here › Welcome · 28 Aug 2025 · 5 likes The compound pages are the fastest way to find out whether a question has a published answer at all. If the page says the trial is ongoing, that is the honest state of…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #49 · Practice › Reconstitution · 27 Aug 2025 · 27 likes Two claims get bundled together under decimal-point error and they need separating. The descriptive one — this is what was observed — is usually well supported. The…
-
Fatigue in the first month: how much is the drug and how much is intake — what changed… Replied, post #53 · Practice › Side effects · 25 Aug 2025 · 6 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Immortal time bias in a claims-database study Replied, post #27 · Evidence › Study critique · 22 Aug 2025 · 9 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Detection wavelength and why 214 nm and 280 nm disagree Replied, post #36 · Analytics › HPLC & UHPLC · 22 Aug 2025 · 0 likes Trifluoroacetic acid at 0.1 per cent is the near-universal ion-pairing additive for this work, and it also raises the baseline at 214 nanometres. That is why the same…
-
Second pass at: LOD and LOQ: definitions people get wrong Replied, post #2 · Analytics › Method validation · 15 Aug 2025 · 3 likes Worth separating two things that the opening post runs together. Where a pharmacopoeial monograph exists, a method that follows it inherits a great deal of assurance.…
-
Coming back to: Why quantitation is the hard part, not detection Replied, post #51 · Analytics › Home & field testing · 14 Aug 2025 · 25 likes Ultraviolet absorbance at 280 nanometres estimates concentration for peptides containing aromatic residues and gives nothing for peptides that do not. Knowing which…
-
Insurance and replacement policies, compared — the long version Replied, post #4 · Sourcing › Logistics · 8 Aug 2025 · 0 likes Post #3 is the version of this I will quote in future. One addition. The bit of Insurance and replacement policies that nobody enjoys is that the answer changes…
-
A ten-fold dose error caught before injection — one year on Replied, post #65 · Devices › Syringes & needles · 3 Aug 2025 · 2 likes Drawing air into the vial before withdrawing liquid equalises the pressure and makes the draw easier. It is not required and it is why some people find a full vial…
-
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #98 · Compounds › Semaglutide · 1 Aug 2025 · 24 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Second pass at: What "verified" means on our vendor pages, stated narrowly Replied, post #2 · Sourcing › Vendor reports · 20 Jul 2025 · 14 likes The arithmetic in the opening post is right; the assumption feeding it is the part to check. Photograph the vial and the label before opening. It costs ten seconds and…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #70 · Compounds › Repair & healing peptides · 15 Jul 2025 · 0 likes A methods point on TB-500 and thymosin beta-4 rather than a substantive one: if the comparison is not like for like, the difference you are measuring is the difference…
-
A field-by-field walk through a certificate of analysis Replied, post #3 · marked as the solution · Analytics › COA interpretation · 13 Jul 2025 · 7 likes Peptide content and chromatographic purity are separate determinations and a certificate that reports only one has answered only one question. Content is the one that…
-
Temperature loggers worth the money Replied, post #8 · Devices › Cold chain · 11 Jul 2025 · 0 likes The bit of temperature loggers worth the money that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Replied, post #29 · Compounds › Cagrilintide & amylin analogues · 8 Jul 2025 · 0 likes Nausea profile of amylin analogues has a well-known answer and a correct answer, and the interesting work is establishing that they are the same. Nobody has done that…
-
Airline travel with a temperature-sensitive injectable — what changed since Replied, post #46 · Devices › Cold chain · 4 Jul 2025 · 0 likes Photographing the parcel on arrival, before opening, takes ten seconds and is the difference between a report and a recollection. Correct me on the arithmetic if it is…
-
Coming back to: Nausea profile of amylin analogues compared with GLP-1 agonists Started this topic · Compounds › Cagrilintide & amylin analogues · 3 Jul 2025 · 2 likes Posting this under the heading it deserves: Nausea profile of amylin analogues compared with GLP-1 agonists Everything below is what sits behind that. Nausea profile of…
-
Asking about a compound your prescriber has not heard of Replied, post #72 · Clinical › Prescriber conversations · 21 Jun 2025 · 0 likes A pharmacist can answer a great many of the questions people save for a prescriber, faster and often better, particularly about interactions and formulations.
-
Asking about a compound your prescriber has not heard of Replied, post #65 · Clinical › Prescriber conversations · 13 Jun 2025 · 30 likes Agreed, and I will stop repeating the version of this I had been repeating.
-
Revisiting: Reading a denial letter as a specification for your appeal Replied, post #13 · Access › Insurance & coverage · 12 Jun 2025 · 15 likes Careful with the language on Reading a denial letter. "Not detected" and "not present" are different findings and the first is a statement about the method.
-
Half-life, steady state, and accumulation worked through Replied, post #97 · Pharmacology › Pharmacokinetics · 11 Jun 2025 · 17 likes Narrowing post #94, because the general version has more than one answer. For anyone finding this later: the short answer on half-life is that it depends on one thing,…
-
Antibiotics and a course of something with delayed emptying Replied, post #55 · Practice › Interactions · 2 Jun 2025 · 18 likes Right, and stated more narrowly than I would have dared to state it.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #122 · Practice › Reconstitution · 1 Jun 2025 · 8 likes Write the reconstitution date and the concentration on the vial. Not on a note, on the vial. Every account here of a dosing error involving the wrong concentration…
-
A supplier that answers analytical questions with restated claims Replied, post #82 · Sourcing › Red flags · 23 May 2025 · 1 like Inconsistency across documents: a certificate stating one purity, a website claiming another, and a supplier's verbal representation claiming a third, all on the same…
-
Pregnancy as an absolute contraindication Replied, post #106 · Safety › Contraindications · 21 May 2025 · 12 likes On post #104 — agreed on the reasoning, with one qualification. Prior hypersensitivity to the product or its excipients is a contraindication that people forget applies…
-
BPC-157: what the rodent literature actually shows, and what it does not — a second… Replied, post #38 · Compounds › Repair & healing peptides · 25 Apr 2025 · 0 likes Post #36 answers the question as asked. The question underneath it is different. The lyophilised cake is worth looking at before adding diluent. A collapsed or shrunken…
-
A page that has drifted out of date and needs a maintainer Replied, post #94 · Documentation › Wiki requests · 24 Apr 2025 · 0 likes The most useful requests here identify a specific confusion that keeps recurring rather than a subject that seems important. That holds under the stated conditions and…
-
Requesting a translation of an existing page Replied, post #11 · Documentation › Wiki requests · 22 Apr 2025 · 0 likes This follows post #8 rather than contradicting it. Translation suggestions: if a maintained page should exist in another language, suggesting it here helps the…
-
Follow-up: Documentation that appears only after payment Replied, post #9 · Sourcing › Red flags · 20 Apr 2025 · 31 likes The most useful contribution to this subcategory is a resolved case written up with the resolution, because the unresolved ones are all anyone remembers. The variance…
-
Transit times by route, from a logged dataset — the long version Replied, post #82 · Sourcing › Logistics · 15 Apr 2025 · 9 likes Adding a data point of agreement rather than a data point.
-
Validating a calculator against hand arithmetic — what changed since Replied, post #3 · Data & Tools › Calculators · 3 Apr 2025 · 17 likes Source for the Validating a calculator against hand figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version…
-
[2026 update] What the GIP component of tirzepatide is thought to contribute, and how… Replied, post #33 · Compounds › Tirzepatide · 1 Apr 2025 · 6 likes Tirzepatide's half-life of roughly five days means steady state is approached in about three weeks rather than four. That is a real difference from semaglutide and it…
-
A supplier that answers analytical questions with restated claims Replied, post #46 · Sourcing › Red flags · 26 Mar 2025 · 0 likes Everything in post #44 holds. The case it does not cover is the one I have. A stock listing that never changes and a lead time that never varies are both worth…
-
Antibiotics and a course of something with delayed emptying Replied, post #6 · Practice › Interactions · 19 Mar 2025 · 6 likes Where a published interaction study exists it usually reports an area-under-curve ratio, and that number is far more informative than a yes-or-no answer.
-
Coming back to: Recording a dissent on a document rather than suppressing it Replied, post #46 · Documentation › Doc review · 12 Mar 2025 · 2 likes Where I part company with post #42, and it is a narrow parting. Point three stops most nominations. A document without a maintainer becomes wrong quietly, and that is…
-
Consistent declarations and why they matter more than clever ones Replied, post #152 · Sourcing › Logistics · 9 Mar 2025 · 0 likes An update on my earlier consistent declarations post: the pattern held for another six weeks and then stopped, which I did not predict and cannot explain.
-
Counter-ion form: the field almost nobody reports — one year on Replied, post #58 · Analytics › COA interpretation · 7 Mar 2025 · 0 likes One caution on Counter-ion form: everything above assumes the underlying documentation is what it claims to be. That assumption is doing real work and is rarely stated.
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #153 · Sourcing › Regulatory · 6 Mar 2025 · 14 likes I read post #151 twice before replying, because I had assumed the opposite. Compounding and pharmacy rules: some jurisdictions allow a pharmacy to compound a drug that…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #69 · Compounds › Semaglutide · 19 Feb 2025 · 3 likes Research-use-only semaglutide is not a licensed medicine, is not manufactured to pharmaceutical standards, and is not approved for human use. That is a statement about…
-
Second pass at: Manufacturer assistance programmes and their eligibility rules Replied, post #6 · Access › Pricing · 15 Feb 2025 · 5 likes Nothing to add on the substance. Thank you for taking the question at face value.
-
Canadian access and provincial variation Replied, post #72 · Regional › North America · 9 Feb 2025 · 27 likes Bookmarking this. I will come back when I have something worth adding.
-
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #20 · Compounds › Other compounds · 8 Feb 2025 · 1 like I read post #16 twice before replying, because I had assumed the opposite. Melanocortin agonists: mechanism involves the melanocortin-4 receptor pathway that regulates…
-
An orphaned page with no inbound links Replied, post #4 · Meta › Wiki maintenance · 28 Jan 2025 · 25 likes Small structural suggestion: the worked examples belong before the general statement rather than after it. Everyone I have watched use this page scrolls straight to the…
-
Research-use-only status: what it means legally and practically — a second dataset Replied, post #61 · Compounds › Other compounds · 11 Jan 2025 · 3 likes Naming conventions for research peptides cause confusion because suppliers do not follow a standard. The same compound gets different names from different suppliers. If…
-
[2026 update] New subcategory: rationale and scope Replied, post #122 · Meta › Announcements · 5 Jan 2025 · 24 likes The question underneath New subcategory is usually "how would I tell?" rather than "what is true?", and that one has a method attached to it. Write down what you would…
-
Feature request: should a dose-equivalence tool exist at all? Replied, post #7 · Data & Tools › Calculators · 2 Jan 2025 · 1 like Post #4 is right about the mechanism and I think understates the practical bit. The residual-volume question belongs in the tool rather than in a footnote, because it…
-
Oxidation and deamidation mass shifts, tabulated Replied, post #28 · Analytics › Mass spectrometry · 31 Dec 2024 · 10 likes A mass match establishes that the measured mass is consistent with the proposed composition. It does not establish purity, sequence order, or the absence of an isomer,…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #57 · Compounds › Oral incretins · 27 Dec 2024 · 0 likes Confirming post #56 from a second method, which matters more than confirming it from a second person. The absorption enhancer in the licensed oral product works by…
-
Follow-up: Where the four-week escalation interval comes from, and what it is not Replied, post #131 · Practice › Dosing & titration · 21 Dec 2024 · 27 likes Saving this. It is the version I will quote when the question comes round again.
-
Converting between mg/mL and units per dose, both directions Replied, post #131 · Practice › Reconstitution · 15 Dec 2024 · 24 likes Choosing a concentration on purpose rather than by accident: starting with "I want to draw 0.5 mL per dose" and working backward to the required concentration is more…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #41 · Sourcing › Regulatory · 9 Dec 2024 · 22 likes Post #40 answers the question as asked. The question underneath it is different. If you can confirm or contradict a position for your own region, please date the…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #72 · Analytics › Method validation · 13 Nov 2024 · 10 likes Everything in post #70 holds. The case it does not cover is the one I have. Limits of detection and quantitation: LOD is the lowest concentration that produces a signal…
-
US compounding rules and how they changed Replied, post #66 · Regional › North America · 10 Nov 2024 · 3 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction.…
-
What would change my mind about repair peptides: a specific answer — one year on Replied, post #5 · Compounds › Repair & healing peptides · 4 Nov 2024 · 0 likes The opening post and I disagree about the size of the effect, not about the direction. What would change the position on repair peptides: adequately powered, published,…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #5 · Devices › Cold chain · 31 Oct 2024 · 9 likes Genuine question rather than a rhetorical one: has anyone here actually observed Domestic fridge temperature mapping, as opposed to read about it? The thread is long…
-
Semaglutide in people without diabetes: what the evidence base looks like Replied, post #3 · Compounds › Semaglutide · 23 Oct 2024 · 24 likes On identity confirmation: a mass close to 4113.6 Da on the intact molecule is consistent with semaglutide and is also consistent with several closely related species.…
-
US compounding rules and how they changed Replied, post #22 · Regional › North America · 13 Oct 2024 · 23 likes Private insurance gaps: some people have private insurance but medication is not covered. Manufacturer assistance programmes are the main resource for cost reduction. I…
-
Pen wastage and its effect on real cost Replied, post #28 · Access › Pricing · 25 Sep 2024 · 23 likes Cost per milligram is the only comparison that survives format differences, and even then it needs care. It is the sort of thing that seems obvious in retrospect and…
-
Hepatic effects of glucagon receptor agonism: the mechanistic worry Replied, post #40 · Compounds › Retatrutide · 16 Sep 2024 · 1 like Adding the measurement that post #39 says would settle it. Reading back through the hepatic effects of glucagon receptor threads from last year, the same three…
-
Request: a diff view for wiki revisions Replied, post #9 · Meta › Feature requests · 4 Sep 2024 · 17 likes The caveat is the whole objection, I think. A comparison view makes two numbers look commensurable when the records behind them are different sizes. This is the version…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #25 · Analytics › Method validation · 1 Sep 2024 · 2 likes The limit of quantitation determines what the impurity table can honestly contain. Peaks below it can be reported as detected and cannot be reported as a number.
-
Progressive overload when the scale is falling — one year on Replied, post #14 · Nutrition & Training › Resistance training · 30 Aug 2024 · 0 likes The thing about Progressive overload that took me longest to accept is that a plausible mechanism is not evidence of an effect. It is a reason to look, not a result.
-
Correlation in a self-tracked dataset: what it can support Replied, post #155 · Research Methods › Statistics · 26 Aug 2024 · 19 likes Second this, and I would have said it less carefully.